Tugwell Barna D, Patel Priti R, Williams Ian T, Hedberg Katrina, Chai Feng, Nainan Omana V, Thomas Ann R, Woll Judith E, Bell Beth P, Cieslak Paul R
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Ann Intern Med. 2005 Nov 1;143(9):648-54. doi: 10.7326/0003-4819-143-9-200511010-00008.
Although hepatitis C virus (HCV) transmission through tissue transplantation has been rarely reported, a donor with undetected viremia may infect several recipients. A patient developed acute hepatitis C shortly after tissue transplantation. Ninety-one tissues or organs had been recovered from the donor.
To determine whether the donor was the source of infection and the extent of transmission to other organ and tissue recipients.
Descriptive epidemiologic study; serum testing for HCV infection.
Recipients were located in 16 states and 2 other countries.
Donor and graft recipients.
Hepatitis C virus infection was defined as the presence of anti-HCV or HCV RNA. The authors determined the genetic relatedness of viral isolates from the donor and recipients by genotype comparison and quasi-species analysis.
The donor was anti-HCV-negative but was HCV RNA-positive (genotype 1a). Forty persons received transplants during 22 months. Five persons were HCV-infected before transplantation or had a genotype other than 1a, and 5 persons had no post-transplantation serum specimens available. Of the remaining 30 recipients, HCV infection occurred in 8 recipients: 3 of 3 organ recipients, 1 of 2 saphenous vein recipients, 1 of 3 tendon recipients, and 3 of 3 tendon with bone recipients. These 8 recipients had viral isolates genetically related to those of the donor. No cases occurred in recipients of skin (n = 2), cornea (n = 1), or irradiated bone (n = 16).
Post-transplantation serum specimens were unavailable for 5 recipients.
An anti-HCV-negative donor was the source of HCV infection for 8 recipients of organs or tissues. Although HCV transmission from anti-HCV-negative donors is probably uncommon, changes in donor screening to include routine testing for HCV RNA merit further consideration to improve the safety of transplantation.
尽管通过组织移植传播丙型肝炎病毒(HCV)的情况鲜有报道,但病毒血症未被检测出的供体可能会感染多名受体。一名患者在组织移植后不久发生了急性丙型肝炎。已从该供体获取了91个组织或器官。
确定该供体是否为感染源以及向其他器官和组织受体的传播范围。
描述性流行病学研究;对HCV感染进行血清检测。
受体分布在16个州和其他2个国家。
供体和移植受体。
丙型肝炎病毒感染定义为抗-HCV或HCV RNA阳性。作者通过基因型比较和准种分析确定了供体和受体病毒分离株的基因相关性。
供体抗-HCV阴性,但HCV RNA阳性(基因型1a)。在22个月期间,40人接受了移植。5人在移植前已感染HCV或具有非1a基因型,5人没有移植后的血清标本。其余30名受体中,8名受体发生了HCV感染:3名器官受体中的3人,2名大隐静脉受体中的1人,3名肌腱受体中的1人,以及3名肌腱加骨受体中的3人。这8名受体的病毒分离株与供体的病毒分离株具有基因相关性。皮肤受体(n = 2)、角膜受体(n = 1)或辐照骨受体(n = 16)中未出现病例。
5名受体没有移植后的血清标本。
一名抗-HCV阴性的供体是8名器官或组织受体的HCV感染源。尽管抗-HCV阴性供体传播HCV的情况可能不常见,但进一步考虑改变供体筛查方式以纳入HCV RNA常规检测,对于提高移植安全性具有重要意义。